This page is part of the Breast Cancer Data Logical Models and FHIR Profiles (v0.1.0: STU 1 Draft) based on FHIR R3. . For a full list of available versions, see the Directory of published versions
{ "resourceType" : "CodeSystem", "id" : "oncology-HER2ISHMethodCS", "text" : { "status" : "generated", "div" : "<div xmlns="http://www.w3.org/1999/xhtml"> <p><b>BC HER2ISHMethodCS CodeSystem</b></p> <p>Value set containing In Situ Hybridization methods of determining HER2 status</p> </div>" }, "url" : "http://hl7.org/fhir/us/breastcancer/CodeSystem/oncology-HER2ISHMethodCS", "identifier" : { "system" : "http://hl7.org/fhir/us/breastcancer", "value" : "oncology.HER2ISHMethodCS" }, "version" : "0.1.0", "name" : "HER2ISHMethodCS", "title" : "BC HER2ISHMethodCS CodeSystem", "status" : "draft", "date" : "2018-04-01T00:00:00+11:00", "publisher" : "The HL7 Cancer Interoperability Group sponsored by Clinical Interoperability Council Work Group (CIC)", "contact" : [ { "telecom" : [ { "system" : "url", "value" : "http://standardhealthrecord.org" } ] } ], "description" : "Value set containing In Situ Hybridization methods of determining HER2 status", "caseSensitive" : true, "content" : "complete", "count" : 2, "concept" : [ { "code" : "single", "display" : "HER2 by Single Probe Assay In Situ Hybridization test", "definition" : "HER2 by Single Probe Assay In Situ Hybridization test" }, { "code" : "dual", "display" : "HER2 by Dual Probe Assay In Situ Hybridization test", "definition" : "HER2 by Dual Probe Assay In Situ Hybridization test" } ] }